Publication dates

All regions

Melanoma Industry, July 2014 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, breast cancer, more »


 
1-20 of about 8 600 reports for Melanoma

Melanoma Drug Pipeline Update 2014

Melanoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Suspended drugs and the accumulated number of ceased drugs over the last years amount to another 134 drugs. melanoma drug pipeline update lists all drugs and gives you a progress analysis on each one of them ...

Melanoma Drug Pathway Analyzer 2014

Melanoma Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the melanoma ...

 Metastatic Melanoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Metastatic Melanoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... And exclusivity details of metastatic melanoma key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under ...

Adaptive Biotechnologies Corporation - Product Pipeline Analysis, 2014 Update

Adaptive Biotechnologies Corporation - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Crohn's disease product overview 11companion diagnostic test - melanoma cancer 12companion diagnostic test - melanoma cancer product overview 12immune system profiling - measure of vaccine ...

 Melanoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Melanoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

... Sales figure from 2011-2015.Reasons to buy - evaluate the marketing status and exclusivity details of melanoma key products to exploit opportunities for generic drug development ...

Metastatic Uveal Melanoma - Pipeline Review, H1 2014

Metastatic Uveal Melanoma - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

... Uveal melanoma pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline productsreasons to buy ...

Physician Views: Five key pre-ASCO questions on the immuno-oncology race

Physician Views: Five key pre-ASCO questions on the immuno-oncology race

  • $ 645
  • Industry report
  • May 2014
  • by Firstword Pharma

... Meeting acted as the catalyst for bullish commercial projections for the first generation of io products, which include bristol-myers squibb's already marketed yervoy (ipilimumab; for melanoma) and the pd-1 ...

MediPoint: Companion Diagnostic Tests in Oncology - Current and Future Players

MediPoint: Companion Diagnostic Tests in Oncology - Current and Future Players

  • $ 3 500
  • Industry report
  • May 2014
  • by Global Data

... Diagnostic tests used in breast, colorectal, melanoma and non-small cell lung cancer. This report also discusses physician attitudes towards current companion diagnostic tests, and the future of companion ...

Global Non-melanoma Skin Cancer Market 2014-2018

Global Non-melanoma Skin Cancer Market 2014-2018

  • $ 3 000
  • Industry report
  • May 2014
  • by Infiniti Research Limited

... In the areas such as the head and neck, whereas scc starts in the face, ears, neck, lips, and backs of the hands. These can also grow in wounds or chronic skin sores. Non-melanoma skin cancer is caused ...

MediPoint: Companion Diagnostic Tests in Oncology - South America Analysis and Market Forecasts

MediPoint: Companion Diagnostic Tests in Oncology - South America Analysis and Market Forecasts

  • $ 4 450
  • Industry report
  • May 2014
  • by Global Data

... Companion diagnostic tests used in breast, colorectal, melanoma and non-small cell lung cancer. This report also discusses physician attitudes towards current companion diagnostic tests, and the future ...

About 1 500 reports for Melanoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe - Forecast

  • May 2014
    5 pages
  • Melanoma  

    Drug  

  • Europe  

    Italy  

    Germany  

View report >

2 Companies for Melanoma

Read our Company Profiles

Novartis Inc.

Switzerland

Eli Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.